The Dilemma of Drug Pricing: Balancing Economics, Regulation and Public Health

Presenter Information

Timothy E. Welty, Drake Pharmacy

Panel

Panel 6: Drug Cost and Access III

Moderator

Keith Hatschek, Professor and Program Director for Music Management and Music Industry Studies, University of the Pacific, Conservatory of Music

Description

The cost of medications is an increasing burden on the healthcare system and on patients. One area associated with the greatest burden is the growing number of specialty medications and biopharmaceutical agents. However, the entire area of pricing of pharmaceutical is extremely complex, with multiple layers of cost drivers. These factors impact not only specialty medications, but all medications. Possible solutions to the issue of medication pricing involve regulatory, legislative, and healthcare delivery changes.

Speaker Bio

Timothy E Welty PharmD FCCP BCPS is Professor and Chair of Clinical Sciences in the College of Pharmacy and Health Sciences at Drake University.

Dr Welty obtained his BS in Pharmacy from Butler University, a MA from Trinity International University, and a PharmD from the University of Minnesota. Additionally, he completed a clinical research fellowship at the University of Minnesota. Dr Welty is a Board Certified Pharmacotherapy Specialist (BCPS). His specialty area of interest and research is in neurology with a focus on epilepsy.

Previous to joining Drake, he served on pharmacy faculties at Purdue University, North Dakota State University, the University of Cincinnati, and Samford University. In these positions, he maintained an active clinical practice and was involved in a number of international initiatives. He has served in leadership roles with a number of national and international pharmacy and medical organizations.

Location

Pacific McGeorge School of Law, Lecture Hall, 3200 Fifth Ave., Sacramento, CA

This document is currently not available here.

Share

COinS
 
Apr 5th, 3:00 PM Apr 5th, 4:00 PM

The Dilemma of Drug Pricing: Balancing Economics, Regulation and Public Health

Pacific McGeorge School of Law, Lecture Hall, 3200 Fifth Ave., Sacramento, CA

The cost of medications is an increasing burden on the healthcare system and on patients. One area associated with the greatest burden is the growing number of specialty medications and biopharmaceutical agents. However, the entire area of pricing of pharmaceutical is extremely complex, with multiple layers of cost drivers. These factors impact not only specialty medications, but all medications. Possible solutions to the issue of medication pricing involve regulatory, legislative, and healthcare delivery changes.